Impact of Lopinavir-Ritonavir or Nevirapine on Bedaquiline Exposures and Potential Implications for Patients with Tuberculosis-HIV Coinfection

類似資料

• Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis
  著者:: Svensson, Elin M., 等
  出版事項: (2013)
• Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children
  著者:: Violari, Avy, 等
  出版事項: (2012)
• Understanding the drug exposure–response relationship of bedaquiline to predict efficacy for novel dosing regimens in the treatment of multidrug‐resistant tuberculosis
  著者:: Tanneau, Lénaïg, 等
  出版事項: (2020)
• Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir
  著者:: Rabie, Helena, 等
  出版事項: (2020)
• Modelling of mycobacterial load reveals bedaquiline’s exposure–response relationship in patients with drug-resistant TB
  著者:: Svensson, Elin M, 等
  出版事項: (2017)